Pas de connexion internet — affichage de la version enregistrée de la page.

Viridian Therapeu…

USUSD
← Vers le Screener
US:VRDNLSE:0K1R

Viridian Therapeutics Inc (US:VRDN) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
viridiantherapeutics.com
Secteur
Health Care · Biotechnology: Pharmaceutical Preparations
Siège Social
WALTHAM, United States
PDG
Stephen F. Mahoney
Employés
252
Actions en Circulation
113.29 M au 2026-08-03
Flottant
100.65 M
Capitalisation Boursière
2.11 Md USD
Initiés
0.17%
Investisseurs Institutionnels
126.76%
Secteur d'Activité (SIC)
Pharmaceutical Preparations
P/E
perte
FCF
−335 M USD
Dette
20.9 M USD
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksVRDN principaleUSD18.66 +1.74%actions ordinaires
LSE London Stock Exchange0K1R IOBUSD18.18 +0.00%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
FMR, LLC14.66%16.6 M2026-06-30
Blackrock Inc.7.55%8.55 M2026-06-30
Bellevue Group AG5.94%6.73 M2026-06-30
Paradigm Biocapital Advi…5.93%6.72 M2026-06-30
Kynam Capital Management…5.7%6.45 M2026-06-30
State Street Corporation5.41%6.12 M2026-06-30
Price (T.Rowe) Associate…5.07%5.75 M2026-06-30
Fairmount Funds Manageme…4.49%5.09 M2026-06-30
Vanguard Capital Managem…4.04%4.58 M2026-06-30
SPDR SERIES TRUST-State…3.65%4.13 M2026-08-31
Deep Track Capital, Lp3.17%3.59 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.95%3.34 M2026-06-30
iShares Trust-iShares Ru…2.04%2.31 M2026-08-31
Fidelity Advisor Series…1.57%1.78 M2026-08-31
Fidelity Select Portfoli…1.32%1.5 M2026-08-31
T. Rowe Price Health Sci…1.28%1.45 M2026-06-30
Fidelity Rutland Square…1.23%1.4 M2026-08-31
T. Rowe Price New Horizo…1.19%1.35 M2026-06-30
Fidelity Select Portfoli…1.15%1.31 M2026-08-31
Fidelity Securities Fund…1.12%1.27 M2026-07-31
TRIPURANENI RADHIKA (Off…≈0.04%40 0002026-08-14
MAHONEY STEPHEN F (Chief…≈0.03%33 3492026-03-03
BEETHAM THOMAS W (Chief…≈0.01%13 3612026-03-03
HARMON SETH (Chief Finan…≈0.01%7 7902026-03-03
TOUSIGNANT JENNIFER (Off…—02026-08-19